Cambridge, United Kingdom
PetaGene specializes in providing secure and transparent compression solutions for genomic data. Founded in 2016, this United Kingdom-based biotechnology startup offers a unique approach to managing the ever-growing genomic data challenges faced by organizations today.
Their multi award-winning software employs lossless compression and encryption to significantly reduce storage and access costs, accelerate data transfers and analyses, and facilitate seamless cloud integration. By ensuring compliance through encryption and deep auditing, PetaGene caters to large pharmaceutical, commercial, clinical, and academic labs, enhancing their genomic workflows without disrupting existing technologies or user experiences.
The company's most recent funding, a Seed Round on 11 May 2023, saw investment from Acequia Capital (AceCap). This round underscores investor confidence in PetaGene's innovative solutions and future growth prospects within the genomic data management sector.
